Patent and Intelectual Property Rights

Patent protection secured in key markets

The company’s intellectual property portfolio consists of several approved patents and patent applications based on unique chemical compounds in the form of aptamer-based drug candidates and their applications. The drug candidates are protected by the strongest form of patent protection in the pharmaceutical industry, entailing that the unique RNA aptamers hold product patent protection.

For recently acquired patentable technology, Aptahem strategically plans to apply for patents in countries that are expected to become key markets for the company in the future. Currently, the following markets are being considered: Europe, the US, Canada and certain important markets in Asia and the rest of the world. The company intends to apply for additional patents in the event that the Board considers that the company should strengthen the intellectual property portfolio further.

Patent family 1

Region Application number/Registration number Application date Expiration date Status
Canada 2714121 2009-02-05 2029-02-05 Granted
China ZL200980111646.4 2009-02-05 2029-02-05 Granted
France 2 247 728 2009-02-05 2029-02-05 Granted
Germany 2 247 728 2009-02-05 2029-02-05 Granted
Great Britain 2 247 728 2009-02-05 2029-02-05 Granted
India 353024 2009-02-05 2029-02-05 Granted
Italy 502015000018390 2009-02-05 2029-02-05 Granted
Spain 2 247 728 2009-02-05 2029-02-05 Granted
Sweden 2 247 728 2009-02-05 2029-02-05 Granted
Switzerland 2 247 728 2009-02-05 2029-02-05 Granted
USA 12/866413 2009-02-05 2029-02-05 Granted

Patent family 2

Region Application number/ Patent number Application date Expiration date Status
Austria 3691655 2017-10-03 2038-10-03 Granted
Brazil 11 2020 005995 1 2017-10-03 2038-10-03 Pending
Canada 3073364 2017-10-03 2038-10-03 Pending
China 2018800643106 2017-10-03 2038-10-03 Pending
France 3691655 2017-10-03 2038-10-03 Granted
Germany 602018022979.5 2017-10-03 2038-10-03 Granted
Great Britain 3691655 2017-10-03 2038-10-03 Granted
Israel 273759 2017-10-03 2038-10-03 Pending
Italy 502021000080276 2017-10-03 2038-10-03 Granted
Japan 2020-519806 2017-10-03 2038-10-03 Pending
The Netherlands 3691655 2017-10-03 2038-10-03 Granted
Poland 3691655 2017-10-03 2038-10-03 Granted
Spain 3691655 2017-10-03 2038-10-03 Granted
South Korea 10-2020-7007266 2017-10-03 2038-10-03 Pending
Sweden 3691655 2017-10-03 2038-10-03 Granted
Switzerland 3691655 2017-10-03 2038-10-03 Granted
Turkey TR 2021/013877 T4 2017-10-03 2038-10-03 Granted
USA 16/652,926 2017-10-03 2038-10-03 Granted